The current published mouse models with continuous MYD88 activation in the B-cell lineage develop aggressive clonal B-cell lymphomas that resemble human ABC-DLBCLs (13–15). The gene discussed is MYD88; the disease is B-cell non-Hodgkin lymphoma.